Nippon Shinyaku Co., Ltd. (4516.T)
JPY 3619.0
(0.33%)
JPY 3619.0
(0.33%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 148.25 Billion JPY | 2.83% |
| 2022 | 144.17 Billion JPY | 4.87% |
| 2021 | 137.48 Billion JPY | 12.8% |
| 2020 | 121.88 Billion JPY | 4.5% |
| 2019 | 116.63 Billion JPY | 1.67% |
| 2018 | 114.71 Billion JPY | 13.08% |
| 2017 | 101.44 Billion JPY | 2.7% |
| 2016 | 98.78 Billion JPY | 17.3% |
| 2015 | 84.2 Billion JPY | 5.27% |
| 2014 | 79.99 Billion JPY | 4.54% |
| 2013 | 76.51 Billion JPY | 9.4% |
| 2012 | 69.94 Billion JPY | 3.92% |
| 2011 | 67.3 Billion JPY | 5.91% |
| 2010 | 63.55 Billion JPY | 0.95% |
| 2009 | 62.95 Billion JPY | -0.14% |
| 2008 | 63.04 Billion JPY | 6.07% |
| 2007 | 59.43 Billion JPY | 5.54% |
| 2006 | 56.32 Billion JPY | 4.38% |
| 2005 | 53.95 Billion JPY | -0.55% |
| 2004 | 54.25 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 39.13 Billion JPY | 10.14% |
| 2023 Q2 | 36.3 Billion JPY | -1.92% |
| 2023 Q1 | 37.01 Billion JPY | 8.05% |
| 2023 FY | 148.25 Billion JPY | 2.83% |
| 2023 Q4 | 35.52 Billion JPY | -9.86% |
| 2023 Q3 | 39.41 Billion JPY | 8.57% |
| 2022 Q3 | 38.78 Billion JPY | 9.2% |
| 2022 Q2 | 35.51 Billion JPY | -0.29% |
| 2022 Q1 | 35.61 Billion JPY | 13.92% |
| 2022 FY | 144.17 Billion JPY | 4.87% |
| 2022 Q4 | 34.25 Billion JPY | -11.67% |
| 2021 FY | 137.48 Billion JPY | 12.8% |
| 2021 Q3 | 34.65 Billion JPY | 13.36% |
| 2021 Q2 | 30.56 Billion JPY | -25.74% |
| 2021 Q1 | 41.15 Billion JPY | 36.97% |
| 2021 Q4 | 31.26 Billion JPY | -9.77% |
| 2020 FY | 121.88 Billion JPY | 4.5% |
| 2020 Q1 | 29.91 Billion JPY | 4.87% |
| 2020 Q3 | 34.02 Billion JPY | 21.92% |
| 2020 Q4 | 30.04 Billion JPY | -11.68% |
| 2020 Q2 | 27.9 Billion JPY | -6.72% |
| 2019 Q2 | 27.99 Billion JPY | -4.75% |
| 2019 Q4 | 28.52 Billion JPY | -7.17% |
| 2019 FY | 116.63 Billion JPY | 1.67% |
| 2019 Q3 | 30.72 Billion JPY | 9.75% |
| 2019 Q1 | 29.39 Billion JPY | 6.12% |
| 2018 Q4 | 27.69 Billion JPY | -17.38% |
| 2018 FY | 114.71 Billion JPY | 13.08% |
| 2018 Q1 | 27.79 Billion JPY | 17.07% |
| 2018 Q2 | 25.69 Billion JPY | -7.55% |
| 2018 Q3 | 33.52 Billion JPY | 30.44% |
| 2017 Q2 | 25.45 Billion JPY | 5.13% |
| 2017 Q1 | 24.21 Billion JPY | 7.51% |
| 2017 FY | 101.44 Billion JPY | 2.7% |
| 2017 Q4 | 23.74 Billion JPY | -15.31% |
| 2017 Q3 | 28.03 Billion JPY | 10.15% |
| 2016 FY | 98.78 Billion JPY | 17.3% |
| 2016 Q1 | 23.74 Billion JPY | 14.45% |
| 2016 Q4 | 22.52 Billion JPY | -29.08% |
| 2016 Q3 | 31.75 Billion JPY | 52.96% |
| 2016 Q2 | 20.76 Billion JPY | -12.56% |
| 2015 FY | 84.2 Billion JPY | 5.27% |
| 2015 Q4 | 20.74 Billion JPY | -13.74% |
| 2015 Q3 | 24.05 Billion JPY | 19.34% |
| 2015 Q2 | 20.15 Billion JPY | 4.64% |
| 2015 Q1 | 19.26 Billion JPY | -9.58% |
| 2014 FY | 79.99 Billion JPY | 4.54% |
| 2014 Q1 | 17.93 Billion JPY | -13.35% |
| 2014 Q2 | 18.53 Billion JPY | 3.3% |
| 2014 Q3 | 22.22 Billion JPY | 19.91% |
| 2014 Q4 | 21.3 Billion JPY | -4.14% |
| 2013 Q3 | 20.22 Billion JPY | 12.48% |
| 2013 FY | 76.51 Billion JPY | 9.4% |
| 2013 Q1 | 17.61 Billion JPY | -4.4% |
| 2013 Q2 | 17.97 Billion JPY | 2.05% |
| 2013 Q4 | 20.7 Billion JPY | 2.39% |
| 2012 Q4 | 18.42 Billion JPY | 0.3% |
| 2012 Q1 | 16.55 Billion JPY | -1.94% |
| 2012 Q3 | 18.37 Billion JPY | 10.74% |
| 2012 Q2 | 16.58 Billion JPY | 0.21% |
| 2012 FY | 69.94 Billion JPY | 3.92% |
| 2011 Q2 | 16.16 Billion JPY | 1.02% |
| 2011 Q3 | 18.25 Billion JPY | 12.88% |
| 2011 Q4 | 16.88 Billion JPY | -7.5% |
| 2011 FY | 67.3 Billion JPY | 5.91% |
| 2011 Q1 | 16 Billion JPY | -3.4% |
| 2010 Q3 | 16.55 Billion JPY | 13.65% |
| 2010 Q2 | 14.57 Billion JPY | -8.09% |
| 2010 Q1 | 15.85 Billion JPY | 9.73% |
| 2010 Q4 | 16.56 Billion JPY | 0.05% |
| 2010 FY | 63.55 Billion JPY | 0.95% |
| 2009 Q4 | 14.44 Billion JPY | -21.55% |
| 2009 FY | 62.95 Billion JPY | -0.14% |
| 2009 Q3 | 18.41 Billion JPY | 28.85% |
| 2009 Q2 | 14.29 Billion JPY | -9.54% |
| 2009 Q1 | 15.79 Billion JPY | 9.65% |
| 2008 Q2 | 14.21 Billion JPY | 0.0% |
| 2008 FY | 63.04 Billion JPY | 6.07% |
| 2008 Q3 | 16.71 Billion JPY | 17.64% |
| 2008 Q4 | 14.4 Billion JPY | -13.81% |
| 2007 FY | 59.43 Billion JPY | 5.54% |
| 2006 FY | 56.32 Billion JPY | 4.38% |
| 2005 FY | 53.95 Billion JPY | -0.55% |
| 2004 FY | 54.25 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 62.14 Billion JPY | -138.555% |
| Takeda Pharmaceutical Company Limited | 4263.76 Billion JPY | 96.523% |
| Sumitomo Pharma Co., Ltd. | 314.55 Billion JPY | 52.869% |
| Shionogi & Co., Ltd. | 435.08 Billion JPY | 65.925% |
| Wakamoto Pharmaceutical Co.,Ltd. | 7.73 Billion JPY | -1815.829% |
| Kaken Pharmaceutical Co., Ltd. | 72.04 Billion JPY | -105.784% |
| Eisai Co., Ltd. | 741.75 Billion JPY | 80.013% |
| Morishita Jintan Co., Ltd. | 12.4 Billion JPY | -1095.027% |
| Hisamitsu Pharmaceutical Co., Inc. | 141.7 Billion JPY | -4.622% |
| Mochida Pharmaceutical Co., Ltd. | 102.88 Billion JPY | -44.098% |
| Fuso Pharmaceutical Industries,Ltd. | 55.4 Billion JPY | -167.579% |
| Nippon Chemiphar Co., Ltd. | 30.74 Billion JPY | -382.161% |
| Tsumura & Co. | 150.84 Billion JPY | 1.717% |
| Kissei Pharmaceutical Co., Ltd. | 75.57 Billion JPY | -96.159% |
| Torii Pharmaceutical Co., Ltd. | 54.63 Billion JPY | -171.34% |
| Towa Pharmaceutical Co., Ltd. | 227.93 Billion JPY | 34.957% |
| Fuji Pharma Co., Ltd. | 40.88 Billion JPY | -262.579% |
| Zeria Pharmaceutical Co., Ltd. | 75.72 Billion JPY | -95.781% |
| KYORIN Holdings, Inc. | 119.53 Billion JPY | -24.03% |
| Taiko Pharmaceutical Co.,Ltd. | 5.04 Billion JPY | -2841.567% |
| Daito Pharmaceutical Co.,Ltd. | 46.89 Billion JPY | -216.142% |
| SymBio Pharmaceuticals Limited | 5.58 Billion JPY | -2552.285% |
| MedRx Co., Ltd | 26 Million JPY | -570111.538% |
| Mizuho Medy Co.,Ltd. | 10.98 Billion JPY | -1249.032% |
| Solasia Pharma K.K. | 617 Million JPY | -23928.363% |
| Modalis Therapeutics Corporation | - JPY | -Infinity% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 62.84 Billion JPY | -135.913% |
| Sawai Group Holdings Co., Ltd. | 176.86 Billion JPY | 16.175% |
| Cyfuse Biomedical K.K. | 61.11 Million JPY | -242495.562% |
| Toho Holdings Co., Ltd. | 1476.71 Billion JPY | 89.96% |
| Koa Shoji Holdings Co.,Ltd. | 22.13 Billion JPY | -569.802% |